论文部分内容阅读
慢性乙型肝炎(CHB)伴脂肪肝对患者健康及生命安全造成严重威胁,因此,加强对该类疾病理想治疗方式进行深入研究具有重要临床价值。本研究主要探讨联合选用恩替卡韦、瑞舒伐他汀两种药物治疗CHB伴有脂肪肝患者的效果,现做如下报告。1资料与方法1.1一般资料2015年1月-2017年1月到本院治疗的CHB伴脂肪肝患者中随机抽取140例,按照随机抽签法将入选者分为两组。参照组70例,男40例,女
Chronic hepatitis B (CHB) with fatty liver poses a serious threat to the health and safety of patients. Therefore, it is of great clinical value to further study the ideal treatment of such diseases. This study focused on the combined use of entecavir, rosuvastatin two drugs in patients with CHB associated with fatty liver effect, are doing the following report. 1 Materials and Methods 1.1 General Information January 2015 January 2017 to our hospital treatment of CHB with fatty liver patients randomly selected 140 cases, according to random selection method will be divided into two groups of participants. Reference group of 70 patients, 40 males and 30 females